Pregled bibliografske jedinice broj: 1253481
Author Correction: Prevalence of potentially inappropriate prescribing in older adults in Central and Eastern Europe: a systematic review and synthesis without meta‑analysis
Author Correction: Prevalence of potentially inappropriate prescribing in older adults in Central and Eastern Europe: a systematic review and synthesis without meta‑analysis // Scientific reports, 12 (2022), 21304, 1 doi:10.1038/s41598-022-25155-9 (nije recenziran, ispravak, ostalo)
CROSBI ID: 1253481 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Author Correction: Prevalence of potentially
inappropriate prescribing in older adults in
Central and Eastern Europe: a systematic review
and synthesis without meta‑analysis
Autori
Brkić, Jovana ; Fialova, Daniela ; Okuyan, Betul ; Kummer, Ingrid ; Šesto, Sofija ; Capiau, Andreas ; Ortner Hadžiabdić, Maja ; Tachkov, Konstantin ; Bobrova, Veera
Izvornik
Scientific reports (2045-2322) 12
(2022);
21304, 1
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, ispravak, ostalo
Ključne riječi
eldery patients ; meta‑analysis
Sažetak
We aimed to systematically review the prevalence of potentially inappropriate prescribing (PIP) in older adults in Central and Eastern Europe (CEE) in all care settings. We searched Embase and MEDLINE (up to June 2019) and checked the reference lists of the included studies and relevant reviews. Eligible studies used validated explicit or implicit tools to assess the PIP prevalence in older adults in CEE. All study designs were considered, except case‒control studies and case series. We assessed the risk of bias using the Joanna Briggs Institute Prevalence Critical Appraisal Tool and the certainty of evidence using the GRADE approach. Meta-analysis was inappropriate due to heterogeneity in the outcome measurements. Therefore, we used the synthesis without meta- analysis approach— summarizing efect estimates method. This review included twenty-seven studies with 139, 693 participants. Most studies were cross- sectional and conducted in high-income countries. The data synthesis across 26 studies revealed the PIP prevalence: the median was 34.6%, the interquartile range was 25.9–63.2%, and the range was 6.5–95.8%. The certainty of this evidence was very low due to the risk of bias, imprecision, and inconsistency. These fndings show that PIP is a prevalent issue in the CEE region. Further well- designed studies conducted across countries are needed to strengthen the existing evidence and increase the generalizability of fndings.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb
Profili:
Maja Ortner Hadžiabdić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
